| |
|
|
|
Cancer Genetics Inc.  
|
|
1.26 0.125 (0.11%) |
09-21 16:00 |
|
Open: |
1.16 |
Pre close: |
1.135 |
Target:
|
1.52 
|
|
High: |
1.3 |
Low: |
1.16 |
Resistance:
|
1.30
1.52
|
|
Volume: |
377,459 |
Market Cap: |
35M |
Support:
|
1.03
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.12
|
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
1.02 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.97 |
Stochastic Oscillator |
%K(14,3):
|
78.45 |
|
MA(250): |
1.63  |
%D(3): |
73.51 |
|
Average Volume(K) |
3-Month: |
10690
|
52-Week |
High:
|
3.50 |
|
10-Days: |
18013 |
Low: |
0.82 |
|
RSI |
RSI(14):
|
79.53 |
Change(%): |
-54.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.800 |
Return on Equity (ttm) |
-91.5 |
Shares Out. (M) |
27.75 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-39.9 |
Shares Float (M) |
24.48 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
-0.04 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
6.5 |
% Held by Institutions |
10.00 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.124 |
Shares Short (K) |
381 |
|
Book Value (p.s.) |
1.690 |
EBITDA (p.s.) |
0.009 |
P/E |
-1.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.75 |
|
Profit Margin |
-54.54 |
Operating Cash Flow
(M) |
-14.28 |
P/S |
28426830.00 |
|
Operating Margin |
-71.63 |
Levered Free Cash Flow
(M) |
-3.66 |
P/CF |
-2.45 |
|
|
|
|
|
|
